Dimer models for ErbB-2/neu transmembrane domains from molecular dynamics simulations

被引:13
|
作者
Sajot, N [1 ]
Garnier, N [1 ]
Genest, M [1 ]
机构
[1] Univ Orleans, UPR 4301 CNRS, Ctr Biophys Mol, F-45071 Orleans 02, France
关键词
ErbB-2/neu transmembrane domains; molecular dynamic simulations; helix-helix association; pi helix deformations;
D O I
10.1007/s002140050408
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Interest in the transmembrane receptors tyrosine kinase of the erbB family is high due to the involvement of some of the members in human cancers. The original oncogenic alleles of neu discovered in rat neuroectodermal tumors lead to single Va1664Glu substitution within the predicted transmembrane domain: Identical substitution at the homologous position 659 constitutively activates the oncogenic potential of the human ErbB-2 receptor by enhanced receptor dimer formation. The precise molecular details of receptor dimerization are still unknown and to acquire more knowledge of the mechanisms involved, molecular dynamics simulations are undertaken to study transmembrane dimer association. Transmembrane helices are predicted to associate in left-handed coiled-coil structures stabilized by Glu-Glu interhelix hydrogen bonds in the mutated form. The internal dynamics reveals pi helix deformations which modify the helix-helix interface. Predicted models agree with those suggested from polarized IR and magic-angle spinning NMR spectroscopy.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [21] Inhibitors of HER2/neu (erbB-2) signal transduction
    Arteaga, CL
    Chinratanalab, W
    Carter, MB
    SEMINARS IN ONCOLOGY, 2001, 28 (06) : 30 - 35
  • [22] CLINICAL-SIGNIFICANCE OF ERBB-2 (HER-2/NEU) PROTEIN
    PAIK, SM
    CANCER INVESTIGATION, 1992, 10 (06) : 575 - 579
  • [23] Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
    Andrechek, ER
    Hardy, WR
    Siegel, PM
    Rudnicki, MA
    Cardiff, RD
    Muller, WJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3444 - 3449
  • [24] THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER
    HYNES, NE
    STERN, DF
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 165 - 184
  • [25] AMPLIFICATION OF ERBB-2 (HER-2/NEU) ONCOGENE IN DIFFERENT NEOPLASMS OF PATIENTS FROM USSR
    KNYAZEV, PG
    IMYANITOV, EN
    CHERNITCA, OI
    NIKIFOROVA, IF
    HANSON, KP
    ONCOLOGY, 1992, 49 (02) : 162 - 165
  • [26] Evaluation of HER-2/neu (erbB-2) status in breast cancer:: From bench to bedside
    Hanna, W
    Kahn, HJ
    Trudeau, M
    MODERN PATHOLOGY, 1999, 12 (08) : 827 - 834
  • [27] Activation of neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface
    Burke, CL
    Stern, DF
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) : 5371 - 5379
  • [28] Initial Structural Models of the Aβ42 Dimer from Replica Exchange Molecular Dynamics Simulations
    Blinov, Nikolay
    Khorvash, Massih
    Wishart, David S.
    Cashman, Neil R.
    Kovalenko, Andriy
    ACS OMEGA, 2017, 2 (11): : 7621 - 7636
  • [29] Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer
    Muller, WJ
    Ho, J
    Siegel, PM
    MAMMARY DEVELOPMENT IN CANCER, 1998, (63): : 149 - 157
  • [30] SIGNAL TRANSDUCTION BY THE NEU/ERBB-2 RECEPTOR - A POTENTIAL TARGET FOR ANTITUMOR THERAPY
    STANCOVSKI, I
    PELES, E
    BENLEVY, R
    LEMPRECHT, R
    KELMAN, Z
    GOLDMANMICHAEL, R
    HURWITZ, E
    BACUS, S
    SELA, M
    YARDEN, Y
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (1-3): : 95 - 103